Search by Practice
Insights & News / Corporate Finance
December 22, 2025
Barnea: Representing Syremis in USD 165 Million Investment Round
Adv. Michael Barnea, Adv. Misha Gitterman, and Adv. Tal Freilich represented Syremis Therapeutics, a spin-off of Clexio Biosciences, in the completion of a USD 165 million Series A financing round co-led by Dexcel Pharma and Third Rock Ventures, with participation from Bain Capital Life Sciences, Google Ventures, and QVT.
July 3, 2025
Mergers and Acquisitions – A Professional Lecture for CFOs by MAI
Adv. Ilan Blumenfeld, a partner and head of the Israeli commercial practice in the firm's Corporate Department, delivered the lecture “The Legal Aspects of Mergers and Acquisitions: Preparing a Company for Sale and/or Merger” as part of the CFO training program organized by the Manufacturers Association of Israel (MAI).
May 19, 2025
Doral Renewables Secures USD 1.3 Billion Financing for Major US Solar Projects
Doral Renewables has successfully closed a landmark USD 1.3 billion financing agreement with HSBC, Santander, and KeyBank to support the development of three of the largest solar energy projects ever built in the United States. Adv. Samuel Henri Samuel and Adv. Nir Alter from our International Commercial Department represented the Doral Group and Migdal entities in this significant US transaction.
March 31, 2024
Representing One Peak in USD 100 Million Financing Round
Adv. Simon Jaffa, Adv. Yuval Lazi, Adv. Mayer Winkler, Adv. Tal Freilich, Adv. Nofar Rose David, and Adv. Dana Ben Yehuda represented UK-based investment management firm One Peak Partners in its investment in Coro, an Israeli cybersecurity startup.
December 7, 2022
Stock Market Skeletons: Adv. Dudi Cohen Interview with Globes
Stock market skeletons are raising their heads. Recently, several skeleton companies have announced talks about merging with private companies who have substantial activity. Adv. Dudi Cohen, head of our firm’s Finance and Public Corporations Department, was interviewed by Globes on the phenomenon. He shed some light on the issue of stock market skeletons and the legal problems that may arise as a result.
November 30, 2022
Shareholder Transactions – Adv. Elad Reshtick Lecture
Adv. Elad Reshtick, a firm partner, lectured to members of a senior business management course on the do’s and don’ts of shareholder transactions. He delivered the lecture to the IDF unit of the Gender Affairs Advisor to the Chief of Staff in cooperation with the Israeli Directors’ Union.
May 3, 2020
Capital Markets in the Age of Coronavirus
MA expert Adv. Micky Barnea was interviewed by Globes for an in-depth analysis of major deal cancellations amid financial uncertainty. The article explores how large corporations have the financial flexibility that smaller businesses and self-employed professionals can only dream of. According to Micky, “Starting in February, we noticed that time had become elastic. Typically, parties seek to maintain a steady pace, accelerating once they have shaken hands on a deal. Now, fewer people are rushing to complete transactions. They are taking time to see what happens next in the market.”
March 19, 2020
Coronavirus: Is a Huge Wave of Debt Arrangement on the Way?
Adv. Micky Barnea was interviewed by Globes on the coronavirus’ effect on both the corporate and government bond markets.
March 29, 2017
Barnea Represents Viola Private Equity in Investment in Similar Web
Barnea represented Viola Private Equity in a USD 50 million investment in Similar Web, a leading digital market intelligence platform that provides insights for websites and applications.
April 5, 2017
Barnea Represents Avgol in Issuance of New Series of Bonds
Barnea represented Avgol Industries 1953 Ltd. in the issuance of a new bond series totaling ILS 197 million. Avgol is one of the world’s largest manufacturers of nonwoven fabrics for the hygiene market, and its securities are included in leading indices on the Tel Aviv Stock Exchange.